Conchi Moreno-Iribas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Conchi Moreno-Iribas has a total of 232 co-authors. Here are the top co-authors by number of shared publications:
- Marcela Guevara
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
11 shared publications - Pilar Amiano
Public Health Division of Gipuzkoa, Biodonostia Research Institute, Donostia-San Sebastian, Spain
11 shared publications - Maria-Jose Sánchez
Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain
9 shared publications - María-Dolores Chirlaque
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
9 shared publications - Antonio Agudo
Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-ICO, and Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
7 shared publications - Paula Jakszyn
Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), 08908 Barcelona, Spain
7 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Springer Nature in Scientific Reports
Adherence to diabetes treatment guidelines and diabetes-related complications: a federated meta-analysis of 90,000 patients with newly diagnosed diabetes
- 28 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessAdherence to diabetes treatment guidelines and diabetes-related complications: a federated meta-analysis of 90,000 patients with newly diagnosed diabetes
- Open Access
Chrono-Nutrition, Chrono-Type, and the Prevalence of Type 2 Diabetes Mellitus in a Cross-Sectional Study from the EuroPean Prospective Investigation into Cancer and Nutrition (EPIC) Study
Background: Previous studies have shown that meal timing, poor sleep quality, and chronotype may play a relevant role in the development of type 2 diabetes mellitus (T2DM). However, its relationship with macronutrients by eating occasions has not been explored deeply. Objective: Our aim was to estimate the association between chrono-nutrition, sleep quality, chronotype, and the prevalence of T2DM. Methods: This cross-sectional study included a subset of 3465 middle-aged Caucasian adults (2068 women) from the European Prospective Investigation into Cancer and Nutrition (EPIC) Spain cohort study. In the 2017–18 follow-up, we assessed chronotype, sleep quality, diet, and sociodemographic data using validated questionnaires. Further, we used blood samples to determine serum levels of glucose. We defined a case of T2DM when serum glucose concentration was ≥126 mg/dL or when participants self-reported diabetes. Results: A higher prevalence of T2DM was associated with poor sleep quality (ORpoorvsgood = 2.90, 95% CI = 1.30, 6.28). Carbohydrate intake at breakfast was inversely associated with the prevalence of T2DM (OR = 0.75, 95% CI = 0.66, 0.85). Finally, lipid intake at breakfast was associated with a 13% higher prevalence of T2DM (OR = 1.13, 95% CI = 1.01, 1.26) for each 1 standard deviation (1-SD) increase. Conclusions: This study concludes that a higher content of carbohydrates at breakfast is correlated with a reduced prevalence of T2DM, while higher lipids intake at breakfast is associated with a higher prevalence of T2DM. Furthermore, poor sleep quality is a potential factor associated with an elevated prevalence of T2DM. Our results emphasize the need for prospective studies to validate and strengthen these observed associations.
Open AccessChrono-Nutrition, Chrono-Type, and the Prevalence of Type 2 Diabetes Mellitus in a Cross-Sectional Study from the EuroPean Prospective Investigation into Cancer and Nutrition (EPIC) Study
Background: Previous studies have shown that meal timing, poor sleep quality, and chronotype may play a relevant role in the development of type 2 diabetes mellitus (T2DM). However, its relationship with macronutrients by eating occasions has not been explored deeply. Objective: Our aim was to estimate the association between chrono-nutrition, sleep quality, chronotype, and the prevalence of T2DM. Methods: This cross-sectional study included a subset of 3465 middle-aged Caucasian adults (2068 women) from the European Prospective Investigation into Cancer and Nutrition (EPIC) Spain cohort study. In the 2017–18 follow-up, we assessed chronotype, sleep quality, diet, and sociodemographic data using validated questionnaires. Further, we used blood samples to determine serum levels of glucose. We defined a case of T2DM when serum glucose concentration was ≥126 mg/dL or when participants self-reported diabetes. Results: A higher prevalence of T2DM was associated with poor sleep quality (ORpoorvsgood = 2.90, 95% CI = 1.30, 6.28). Carbohydrate intake at breakfast was inversely associated with the prevalence of T2DM (OR = 0.75, 95% CI = 0.66, 0.85). Finally, lipid intake at breakfast was associated with a 13% higher prevalence of T2DM (OR = 1.13, 95% CI = 1.01, 1.26) for each 1 standard deviation (1-SD) increase. Conclusions: This study concludes that a higher content of carbohydrates at breakfast is correlated with a reduced prevalence of T2DM, while higher lipids intake at breakfast is associated with a higher prevalence of T2DM. Furthermore, poor sleep quality is a potential factor associated with an elevated prevalence of T2DM. Our results emphasize the need for prospective studies to validate and strengthen these observed associations.
- Open Access
- 31 July 2024
- Published by MDPI AG in Preprints.org
Chrono-Nutrition, Chrono-Type, and the Prevalence of Type 2 Diabetes Mellitus in a Cross-Sectional Study from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Background: It has shown that meal timing, poor sleep quality and chronotype could play a relevant role in the development of type 2 diabetes mellitus (T2DM). However, the relationship with macronutrients by eating occasions has not been explored deeply. Objective: Our aim was to estimate the association between chrono-nutrition, sleep quality, chronotype and the prevalence of T2DM. Methods: This cross-sectional study included a subset of 3465 middle-aged adults (2068 women) from the European Prospective Investigation into Cancer and Nutrition (EPIC) Spain cohort study. In the 2017-18 follow-up, we assessed chronotype, sleep quality, diet, and sociodemographic data by validated questionnaires. Further, we used blood samples to determinate serum levels of glucose. We defined a case of T2DM when serum glucose concentration was ≥126 mg/dl or when participants self-reported diabetes. Results: Higher prevalence of T2DM was associated with poor sleep quality (ORpoorvsgood=2.90, 95%CI=1.30, 6.28). Carbohydrate intake at breakfast was inversely associated with the prevalence of T2DM (OR=0.75, 95%CI=0.66, 0.85). Finally, lipid intake at breakfast were associated with a 13% higher the prevalence of T2DM (OR=1.13, 95%CI=1.01, 1.26) for each 1 standard deviation (1-SD) increase. We observed no associations between macronutrient intake at lunch or dinner and T2DM. Conclusions: The study concludes that a breakfast with higher content in carbohydrate at breakfast is correlated with a reduced prevalence of T2DM. While higher lipids intake at breakfast was associated with higher prevalence of T2DM. Furthermore, poor sleep quality is as a potential factor associated with an elevated prevalence of T2DM. Our results emphasize the need for prospective studies to validate and strengthen these observed associations.
- 31 July 2024
- Published by MDPI AG in Preprints.org
Open AccessChrono-Nutrition, Chrono-Type, and the Prevalence of Type 2 Diabetes Mellitus in a Cross-Sectional Study from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Background: It has shown that meal timing, poor sleep quality and chronotype could play a relevant role in the development of type 2 diabetes mellitus (T2DM). However, the relationship with macronutrients by eating occasions has not been explored deeply. Objective: Our aim was to estimate the association between chrono-nutrition, sleep quality, chronotype and the prevalence of T2DM. Methods: This cross-sectional study included a subset of 3465 middle-aged adults (2068 women) from the European Prospective Investigation into Cancer and Nutrition (EPIC) Spain cohort study. In the 2017-18 follow-up, we assessed chronotype, sleep quality, diet, and sociodemographic data by validated questionnaires. Further, we used blood samples to determinate serum levels of glucose. We defined a case of T2DM when serum glucose concentration was ≥126 mg/dl or when participants self-reported diabetes. Results: Higher prevalence of T2DM was associated with poor sleep quality (ORpoorvsgood=2.90, 95%CI=1.30, 6.28). Carbohydrate intake at breakfast was inversely associated with the prevalence of T2DM (OR=0.75, 95%CI=0.66, 0.85). Finally, lipid intake at breakfast were associated with a 13% higher the prevalence of T2DM (OR=1.13, 95%CI=1.01, 1.26) for each 1 standard deviation (1-SD) increase. We observed no associations between macronutrient intake at lunch or dinner and T2DM. Conclusions: The study concludes that a breakfast with higher content in carbohydrate at breakfast is correlated with a reduced prevalence of T2DM. While higher lipids intake at breakfast was associated with higher prevalence of T2DM. Furthermore, poor sleep quality is as a potential factor associated with an elevated prevalence of T2DM. Our results emphasize the need for prospective studies to validate and strengthen these observed associations.
- Open Access
The EAT-Lancet Planetary Health Diet: Impact on Cardiovascular Disease and the Environment in the EPIC Cohort
Background: Diet plays an important role in the development of cardiovascular diseases and in maintaining sustainable planetary boundaries. The EAT-Lancet Planetary Health Diet could potentially provide co-benefits for human and environmental health, yet evidence on the association between adherence to the EAT-Lancet Planetary Health Diet and risk of cardiovascular events and environmental impact is limited. Methods: We investigated the association between adherence to the EAT-Lancet diet and coronary heart disease (CHD) and stroke risk, and with greenhouse gas (GHG) emissions, land use, and dietary species richness (DSR). We included 364,745 adult men and women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Food frequency questionnaires were used to create a score reflecting adherence to the EAT-Lancet diet (EAT-Lancet diet-score), ranging from 0 (no adherence) to 140 (complete adherence). A (pro-) vegetarian version of the score, the EAT-Lancet dietVV-score, was also created, which rewarded low to no consumption of all animal-based foods. Cox proportional hazard regressions were used to study the association of adherence to the EAT-Lancet diet with CHD and stroke incidence. Linear regression analyzed the association with GHG emissions, land use, and DSR. Findings: Over a median follow-up of 12·8 years, we identified 12,690 CHD and 7,088 stroke cases. After multivariable adjustment, those most adherent to the EAT-Lancet diet had lower risk of incident stroke (HR Q5vsQ1 : 0·59, 95%CI = 0·54 to 0·64), and of incident CHD for those younger than 60 years old at baseline (HR Q5vsQ1 : 0·86, 95%CI = 0·79 to 0·93). High adherence to the EAT-Lancet diet reduced GHG emissions by 1·7% (95%CI = -1·9 to -1·5) and land use by 6·2% (95%CI = -6·4 to -5·9). The EAT-Lancet dietVV-score further reduced GHG emissions and land use by 14·3% (95%CI= -14·5 to -14·0) and 18·8% (95%CI = -19·0 to -18·5), respectively, when comparing extreme quintiles, while hazard ratios for CHD and stroke remained unchanged. Those most adherent to the EAT-Lancet diet consumed 16·1% (95%CI = 15·9 to 16·4) more plant species and 19·7% (95%CI = -20·11 to -19·40) fewer animal species. Interpretation: Higher adherence to the EAT-Lancet diet was associated with co-benefits for both cardiovascular outcomes and environmental indicators, including dietary species richness. Lower GHG emissions and land use were achieved by further reducing consumption of animal-based products. Funding: The coordination of EPIC-Europe is financially supported by the International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). Exposure indicators were calculated with financial support of the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme (IIG_FULL_2020_034). Research in context: Evidence before this study: The authors considered all evidence available to them on the EAT-Lancet Planetary Health Diet, published up until May 2024. The authors searched for relevant articles on the association between adherence to the diet and cardiovascular outcomes and environmental indicators. Studies investigating the association between the diet and outcomes not of interest in this study were not considered. We restricted to evidence from prospective cohort studies with similar analyses and methodology, thereby excluding studies modelling the environmental impact. We found two research articles that explored the association of EAT-Lancet Planetary Health Diet with both cardiovascular outcomes and environmental impact, four that only assessed the association with cardiovascular outcomes, and three only focused on environmental indicators. We found no studies on the association between adherence to the EAT-Lancet Planetary Health Diet and food biodiversity. These studies spanned across varied population groups, focused on different cardiovascular endpoints and reported inconclusive evidence. This also streams from the use of different scores and indices to measure adherence to the EAT-Lancet Planetary Health Diet, which strongly influences evidence on risk estimates. Similarly, evidence on greenhouses gas emissions and land use are hindered by the use of different methodologies to calculate the associated environmental impact of foods and beverages. Added value of this study: This study benefits from the use of a large pan-European cohort, which used a standardized nutrient and food database to determine individual dietary intake, as well as environmental data derived by Life Cycle Assessment analyses validated at the European level. The use of two diet scores—one representing an omnivorous version of the EAT-Lancet Planeatry Health Diet (EAT-Lancet diet-score) and the other representing a plant-based variation (EAT-Lancet dietVV-score) —demonstrates that greater environmental benefits can be achieved with the EAT-Lancet dietVV-score by further restricting consumption of animal-based products, without impacting the benefits on human health. The study adds to the current evidence on the impact of the EAT-Lancet Planetary Health Diet on both cardiovascular health and environmental well-being, and additionally supports evidence of an association between adherence to the EAT-Lancet Planetary Health Diet and food biodiversity. The association with food biodiversity adds an important complementary measure of health and sustainability to the current body of evidence on co-benefits of the EAT-Lancet Planetary Health Diet. Implications of all the available evidence: Our findings substantiate the co-benefits of adherence to the EAT-Lancet Planeatry Health Diet found in previous studies for cardiovascular health and environmental indicators, with evidence from a large pan-European population-based study. This research study found evidence that adherence to the EAT-Lancet diet was associated with lower risk of stroke across the whole population and with lower risk of CHD among those younger than 60 years old. This study also highlights the impact of the ways in which we operationalise adherence to the EAT-Lancet Planetary Health Diet, emphasizing its importance for comparing studies and developing national policies.
Open AccessThe EAT-Lancet Planetary Health Diet: Impact on Cardiovascular Disease and the Environment in the EPIC Cohort
Background: Diet plays an important role in the development of cardiovascular diseases and in maintaining sustainable planetary boundaries. The EAT-Lancet Planetary Health Diet could potentially provide co-benefits for human and environmental health, yet evidence on the association between adherence to the EAT-Lancet Planetary Health Diet and risk of cardiovascular events and environmental impact is limited. Methods: We investigated the association between adherence to the EAT-Lancet diet and coronary heart disease (CHD) and stroke risk, and with greenhouse gas (GHG) emissions, land use, and dietary species richness (DSR). We included 364,745 adult men and women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Food frequency questionnaires were used to create a score reflecting adherence to the EAT-Lancet diet (EAT-Lancet diet-score), ranging from 0 (no adherence) to 140 (complete adherence). A (pro-) vegetarian version of the score, the EAT-Lancet dietVV-score, was also created, which rewarded low to no consumption of all animal-based foods. Cox proportional hazard regressions were used to study the association of adherence to the EAT-Lancet diet with CHD and stroke incidence. Linear regression analyzed the association with GHG emissions, land use, and DSR. Findings: Over a median follow-up of 12·8 years, we identified 12,690 CHD and 7,088 stroke cases. After multivariable adjustment, those most adherent to the EAT-Lancet diet had lower risk of incident stroke (HR Q5vsQ1 : 0·59, 95%CI = 0·54 to 0·64), and of incident CHD for those younger than 60 years old at baseline (HR Q5vsQ1 : 0·86, 95%CI = 0·79 to 0·93). High adherence to the EAT-Lancet diet reduced GHG emissions by 1·7% (95%CI = -1·9 to -1·5) and land use by 6·2% (95%CI = -6·4 to -5·9). The EAT-Lancet dietVV-score further reduced GHG emissions and land use by 14·3% (95%CI= -14·5 to -14·0) and 18·8% (95%CI = -19·0 to -18·5), respectively, when comparing extreme quintiles, while hazard ratios for CHD and stroke remained unchanged. Those most adherent to the EAT-Lancet diet consumed 16·1% (95%CI = 15·9 to 16·4) more plant species and 19·7% (95%CI = -20·11 to -19·40) fewer animal species. Interpretation: Higher adherence to the EAT-Lancet diet was associated with co-benefits for both cardiovascular outcomes and environmental indicators, including dietary species richness. Lower GHG emissions and land use were achieved by further reducing consumption of animal-based products. Funding: The coordination of EPIC-Europe is financially supported by the International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). Exposure indicators were calculated with financial support of the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme (IIG_FULL_2020_034). Research in context: Evidence before this study: The authors considered all evidence available to them on the EAT-Lancet Planetary Health Diet, published up until May 2024. The authors searched for relevant articles on the association between adherence to the diet and cardiovascular outcomes and environmental indicators. Studies investigating the association between the diet and outcomes not of interest in this study were not considered. We restricted to evidence from prospective cohort studies with similar analyses and methodology, thereby excluding studies modelling the environmental impact. We found two research articles that explored the association of EAT-Lancet Planetary Health Diet with both cardiovascular outcomes and environmental impact, four that only assessed the association with cardiovascular outcomes, and three only focused on environmental indicators. We found no studies on the association between adherence to the EAT-Lancet Planetary Health Diet and food biodiversity. These studies spanned across varied population groups, focused on different cardiovascular endpoints and reported inconclusive evidence. This also streams from the use of different scores and indices to measure adherence to the EAT-Lancet Planetary Health Diet, which strongly influences evidence on risk estimates. Similarly, evidence on greenhouses gas emissions and land use are hindered by the use of different methodologies to calculate the associated environmental impact of foods and beverages. Added value of this study: This study benefits from the use of a large pan-European cohort, which used a standardized nutrient and food database to determine individual dietary intake, as well as environmental data derived by Life Cycle Assessment analyses validated at the European level. The use of two diet scores—one representing an omnivorous version of the EAT-Lancet Planeatry Health Diet (EAT-Lancet diet-score) and the other representing a plant-based variation (EAT-Lancet dietVV-score) —demonstrates that greater environmental benefits can be achieved with the EAT-Lancet dietVV-score by further restricting consumption of animal-based products, without impacting the benefits on human health. The study adds to the current evidence on the impact of the EAT-Lancet Planetary Health Diet on both cardiovascular health and environmental well-being, and additionally supports evidence of an association between adherence to the EAT-Lancet Planetary Health Diet and food biodiversity. The association with food biodiversity adds an important complementary measure of health and sustainability to the current body of evidence on co-benefits of the EAT-Lancet Planetary Health Diet. Implications of all the available evidence: Our findings substantiate the co-benefits of adherence to the EAT-Lancet Planeatry Health Diet found in previous studies for cardiovascular health and environmental indicators, with evidence from a large pan-European population-based study. This research study found evidence that adherence to the EAT-Lancet diet was associated with lower risk of stroke across the whole population and with lower risk of CHD among those younger than 60 years old. This study also highlights the impact of the ways in which we operationalise adherence to the EAT-Lancet Planetary Health Diet, emphasizing its importance for comparing studies and developing national policies.
- 28 March 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (6) , 854-856
Nitrosyl-heme and Heme Iron Intake from Processed Meats and Risk of Colorectal Cancer in the EPIC-Spain Cohort
Background: The International Agency for Research on Cancer classified processed meats (PM) as “carcinogenic” and red meat as “probably carcinogenic” for humans. The possible relationship between colorectal cancer risk and the mechanisms involved in the carcinogenesis of PMs have not been established yet. Nitrosyl-heme and heme iron have been proposed as potential-related compounds. The aim of this study was to determine the association between nitrosyl-heme and heme iron intake and colorectal cancer risk among participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain study. Methods: This prospective study included 38,262 men and women from the EPIC-Spain study. Food consumption was assessed using diet history and food composition tables. Heme iron and nitrosyl-heme intake were determined by estimating the intake of PM items and conducting laboratory analyses. HR estimates were obtained by proportional hazard models, stratified by age at recruitment and study center and adjusted for sex, total energy intake, education, smoking, body mass index, waist size, physical activity, lifetime alcohol, fibre, calcium, and familiar colorectal cancer history. Results: During a mean follow-up of 16.7 years, 577 participants were diagnosed with colorectal cancer. We found no overall association between nitrosyl-heme [HRT3vsT1, 0.98; 95% confidence interval (CI), 0.79–1.21] or heme iron intakes (HRT3vsT1, 0.88; 95% CI, 0.70–1.10) with colorectal cancer risk, nor according to tumor subtypes. Conclusions: Our study found no evidence supporting a link between nitrosyl-heme or heme iron intake and colorectal cancer risk in Spanish subjects. Impact: As research on nitrosyl-heme is preliminary, more heterogeneous studies are necessary to provide more convincing evidence on their role in colorectal cancer carcinogenesis.
- 28 March 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (6) , 854-856
Nitrosyl-heme and Heme Iron Intake from Processed Meats and Risk of Colorectal Cancer in the EPIC-Spain Cohort
Background: The International Agency for Research on Cancer classified processed meats (PM) as “carcinogenic” and red meat as “probably carcinogenic” for humans. The possible relationship between colorectal cancer risk and the mechanisms involved in the carcinogenesis of PMs have not been established yet. Nitrosyl-heme and heme iron have been proposed as potential-related compounds. The aim of this study was to determine the association between nitrosyl-heme and heme iron intake and colorectal cancer risk among participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain study. Methods: This prospective study included 38,262 men and women from the EPIC-Spain study. Food consumption was assessed using diet history and food composition tables. Heme iron and nitrosyl-heme intake were determined by estimating the intake of PM items and conducting laboratory analyses. HR estimates were obtained by proportional hazard models, stratified by age at recruitment and study center and adjusted for sex, total energy intake, education, smoking, body mass index, waist size, physical activity, lifetime alcohol, fibre, calcium, and familiar colorectal cancer history. Results: During a mean follow-up of 16.7 years, 577 participants were diagnosed with colorectal cancer. We found no overall association between nitrosyl-heme [HRT3vsT1, 0.98; 95% confidence interval (CI), 0.79–1.21] or heme iron intakes (HRT3vsT1, 0.88; 95% CI, 0.70–1.10) with colorectal cancer risk, nor according to tumor subtypes. Conclusions: Our study found no evidence supporting a link between nitrosyl-heme or heme iron intake and colorectal cancer risk in Spanish subjects. Impact: As research on nitrosyl-heme is preliminary, more heterogeneous studies are necessary to provide more convincing evidence on their role in colorectal cancer carcinogenesis.
- Open Access
Nitrosyl-Heme and Heme Iron Intake from Processed Meats in Subjects from the EPIC-Spain Cohort
Background: The consumption of processed meats (PMs) and red meats are linked to the likelihood of developing colorectal cancer. Various theories have been proposed to explain this connection, focusing on nitrosyl-heme and heme iron intake. We hypothesized that differences in nitrosyl-heme and heme iron intakes will be associated with various sociodemographic and lifestyle factors. Methods: The study included 38,471 healthy volunteers (62% females) from five Spanish regions within the EPIC-Spain cohort. High-Performance Liquid Chromatography (HPLC) determined nitrosyl-heme and heme iron levels in the 39 most consumed PMs. Food intake was assessed using validated questionnaires in interviews. Nitrosyl-heme and heme iron intakes, adjusted for sex, age, body mass index (BMI), center, and energy intake, were expressed as geometric means due to their skewed distribution. Variance analysis identified foods explaining the variability of nitrosyl-heme and heme iron intakes. Results: The estimated intakes were 528.6 µg/day for nitrosyl-heme and 1676.2 µg/day for heme iron. Significant differences in nitrosyl-heme intake were found by sex, center, energy, and education level. Heme iron intake varied significantly by sex, center, energy, and smoking status. “Jamón serrano” and “jamón cocido/jamón de York” had the highest intake values, while “morcilla asturiana” and “sangrecilla” were key sources of nitrosyl-heme and heme iron. Conclusions: This is the first study to estimate levels of nitrosyl-heme intake directly in PMs for a large sample, revealing variations based on sex, BMI, smoking, and activity. Its data aids future exposure estimations in diverse populations.
Open AccessNitrosyl-Heme and Heme Iron Intake from Processed Meats in Subjects from the EPIC-Spain Cohort
Background: The consumption of processed meats (PMs) and red meats are linked to the likelihood of developing colorectal cancer. Various theories have been proposed to explain this connection, focusing on nitrosyl-heme and heme iron intake. We hypothesized that differences in nitrosyl-heme and heme iron intakes will be associated with various sociodemographic and lifestyle factors. Methods: The study included 38,471 healthy volunteers (62% females) from five Spanish regions within the EPIC-Spain cohort. High-Performance Liquid Chromatography (HPLC) determined nitrosyl-heme and heme iron levels in the 39 most consumed PMs. Food intake was assessed using validated questionnaires in interviews. Nitrosyl-heme and heme iron intakes, adjusted for sex, age, body mass index (BMI), center, and energy intake, were expressed as geometric means due to their skewed distribution. Variance analysis identified foods explaining the variability of nitrosyl-heme and heme iron intakes. Results: The estimated intakes were 528.6 µg/day for nitrosyl-heme and 1676.2 µg/day for heme iron. Significant differences in nitrosyl-heme intake were found by sex, center, energy, and education level. Heme iron intake varied significantly by sex, center, energy, and smoking status. “Jamón serrano” and “jamón cocido/jamón de York” had the highest intake values, while “morcilla asturiana” and “sangrecilla” were key sources of nitrosyl-heme and heme iron. Conclusions: This is the first study to estimate levels of nitrosyl-heme intake directly in PMs for a large sample, revealing variations based on sex, BMI, smoking, and activity. Its data aids future exposure estimations in diverse populations.
- Open Access
- 14 March 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (3) , 441-448
Sex-dependent effect of socioeconomic status on cardiovascular event risk in a population-based cohort of patients with type 2 diabetes
Background: Socioeconomic status (SES) factors often result in profound health inequalities among populations, and their impact may differ between sexes. The aim of this study was to estimate and compare the effect of socioeconomic status indicators on incident cardiovascular disease (CVD)-related events among males and females with type 2 diabetes (T2D). Methods: A population-based cohort from a southern European region including 24,650 patients with T2D was followed for five years. The sex-specific associations between SES indicators and the first occurring CVD event were modeled using multivariate Fine-Gray competing risk models. Coronary Heart Disease (CHD) and stroke were considered secondary outcomes. Results: Patients without a formal education had a significantly higher risk of CVD than those with a high school or university education, with adjusted hazard ratios (HRs) equal to 1.24 (95%CI: 1.09–1.41) for males and 1.50 (95%CI: 1.09–2.06) for females. Patients with <18 000€ income had also higher CVD risk than those with ≥18 000€, with HRs equal to 1.44 (95%CI: 1.29–1.59) for males and 1.42 (95%CI: 1.26–1.60) for females. Being immigrant showed a HR equal to 0.81 (95%CI: 0.66–0.99) for males and 1.13 (95%CI: 0.68–1.87) for females. Similar results were observed for stroke, but differed for CHD when income is used, which had higher effect in females. Conclusion: Socioeconomic inequalities in CVD outcomes are present among T2D patients, and their magnitude for educational attainment is sex-dependent, being higher in females, suggesting the need to consider them when designing tailored primary prevention and management strategies.
- 14 March 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (3) , 441-448
Open AccessSex-dependent effect of socioeconomic status on cardiovascular event risk in a population-based cohort of patients with type 2 diabetes
Background: Socioeconomic status (SES) factors often result in profound health inequalities among populations, and their impact may differ between sexes. The aim of this study was to estimate and compare the effect of socioeconomic status indicators on incident cardiovascular disease (CVD)-related events among males and females with type 2 diabetes (T2D). Methods: A population-based cohort from a southern European region including 24,650 patients with T2D was followed for five years. The sex-specific associations between SES indicators and the first occurring CVD event were modeled using multivariate Fine-Gray competing risk models. Coronary Heart Disease (CHD) and stroke were considered secondary outcomes. Results: Patients without a formal education had a significantly higher risk of CVD than those with a high school or university education, with adjusted hazard ratios (HRs) equal to 1.24 (95%CI: 1.09–1.41) for males and 1.50 (95%CI: 1.09–2.06) for females. Patients with <18 000€ income had also higher CVD risk than those with ≥18 000€, with HRs equal to 1.44 (95%CI: 1.29–1.59) for males and 1.42 (95%CI: 1.26–1.60) for females. Being immigrant showed a HR equal to 0.81 (95%CI: 0.66–0.99) for males and 1.13 (95%CI: 0.68–1.87) for females. Similar results were observed for stroke, but differed for CHD when income is used, which had higher effect in females. Conclusion: Socioeconomic inequalities in CVD outcomes are present among T2D patients, and their magnitude for educational attainment is sex-dependent, being higher in females, suggesting the need to consider them when designing tailored primary prevention and management strategies.
- Open Access
- 19 September 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (18) , e030280
Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women
Background: Observational studies have shown that women with an early menopause are at higher risk of stroke compared with women with a later menopause. However, associations with stroke subtypes are inconsistent, and the causality is unclear. Methods and Results: We analyzed data of the UK Biobank and EPIC‐CVD (European Prospective Investigation Into Cancer and Nutrition‐Cardiovascular Diseases) study. A total of 204 244 postmenopausal women without a history of stroke at baseline were included (7883 from EPIC‐CVD [5292 from the subcohort], 196 361 from the UK Biobank). Pooled mean baseline age was 58.9 years (SD, 5.8), and pooled mean age at menopause was 47.8 years (SD, 6.2). Over a median follow‐up of 12.6 years (interquartile range, 11.8–13.3), 6770 women experienced a stroke (5155 ischemic strokes, 1615 hemorrhagic strokes, 976 intracerebral hemorrhages, and 639 subarachnoid hemorrhages). In multivariable adjusted observational Cox regression analyses, the pooled hazard ratios per 5 years younger age at menopause were 1.09 (95% CI, 1.07–1.12) for stroke, 1.09 (95% CI, 1.06–1.13) for ischemic stroke, 1.10 (95% CI, 1.04–1.16) for hemorrhagic stroke, 1.14 (95% CI, 1.08–1.20) for intracerebral hemorrhage, and 1.00 (95% CI, 0.84–1.20) for subarachnoid hemorrhage. When using 2‐sample Mendelian randomization analysis, we found no statistically significant association between genetically proxied age at menopause and risk of any type of stroke. Conclusions: In our study, earlier age at menopause was related to a higher risk of stroke. We found no statistically significant association between genetically proxied age at menopause and risk of stroke, suggesting no causal relationship.
- 19 September 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (18) , e030280
Open AccessAge at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women
Background: Observational studies have shown that women with an early menopause are at higher risk of stroke compared with women with a later menopause. However, associations with stroke subtypes are inconsistent, and the causality is unclear. Methods and Results: We analyzed data of the UK Biobank and EPIC‐CVD (European Prospective Investigation Into Cancer and Nutrition‐Cardiovascular Diseases) study. A total of 204 244 postmenopausal women without a history of stroke at baseline were included (7883 from EPIC‐CVD [5292 from the subcohort], 196 361 from the UK Biobank). Pooled mean baseline age was 58.9 years (SD, 5.8), and pooled mean age at menopause was 47.8 years (SD, 6.2). Over a median follow‐up of 12.6 years (interquartile range, 11.8–13.3), 6770 women experienced a stroke (5155 ischemic strokes, 1615 hemorrhagic strokes, 976 intracerebral hemorrhages, and 639 subarachnoid hemorrhages). In multivariable adjusted observational Cox regression analyses, the pooled hazard ratios per 5 years younger age at menopause were 1.09 (95% CI, 1.07–1.12) for stroke, 1.09 (95% CI, 1.06–1.13) for ischemic stroke, 1.10 (95% CI, 1.04–1.16) for hemorrhagic stroke, 1.14 (95% CI, 1.08–1.20) for intracerebral hemorrhage, and 1.00 (95% CI, 0.84–1.20) for subarachnoid hemorrhage. When using 2‐sample Mendelian randomization analysis, we found no statistically significant association between genetically proxied age at menopause and risk of any type of stroke. Conclusions: In our study, earlier age at menopause was related to a higher risk of stroke. We found no statistically significant association between genetically proxied age at menopause and risk of stroke, suggesting no causal relationship.
- Open Access
- 16 August 2023
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 46 (2)
Survival of cancer patients in Navarre and comparison with Spain
To analyze the survival of adult cancer patients in Navarre, describe its trend, and compare the data for this Spanish Autonomous Community against that reported for Spain. Records of adult cancer patients were retrieved from the Navarre´s population-based cancer registry for two periods (1999-2007 and 2008-2016). The vital status had been updated to 2020. Observed survival, net survival and age-standardized net survival at five years with 95% confidence intervals were estimated overall and for twenty-nine cancer groups. We analyzed 57,564 cases. Age-standardized net survival was 59.9% (59.1-60.8) and 63.8% (62.8-64.7) for males and females diagnosed with cancer during the 2008-2016 period, respectively. Age-standardized net survival ranged from 13.4% (10.4-17.4) for pancreatic cancer to 94.0% (88.1-100) for thyroid cancer in male patients, and from 11.9% (7.2-19.7) for liver cancer to 95.6% (92.6-98.6-%) for thyroid cancer in female patients. Compared with cases diagnosed in the 1999-2007 period, age-standardized net survival increased in 10 cancer groups, resulting in an overall increase of 5.1 (4.1-6.0) percentage points. The age-standardized net survival in Navarre was 2.7 (1.9-3.4) percentage points higher than that described for Spain for the 2008-2013 period. In Navarre, the survival of cancer patients diagnosed during the 2008-2016 period improved significantly in comparison to the 1999-2007 period. Different factors may explain this improvement, including earlier diagnoses, more effective treatment options, and better healthcare processes. Overall, survival was higher in women than in men. Our results suggest a higher survival rate in Navarre than in Spain.
- 16 August 2023
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 46 (2)
Open AccessSurvival of cancer patients in Navarre and comparison with Spain
To analyze the survival of adult cancer patients in Navarre, describe its trend, and compare the data for this Spanish Autonomous Community against that reported for Spain. Records of adult cancer patients were retrieved from the Navarre´s population-based cancer registry for two periods (1999-2007 and 2008-2016). The vital status had been updated to 2020. Observed survival, net survival and age-standardized net survival at five years with 95% confidence intervals were estimated overall and for twenty-nine cancer groups. We analyzed 57,564 cases. Age-standardized net survival was 59.9% (59.1-60.8) and 63.8% (62.8-64.7) for males and females diagnosed with cancer during the 2008-2016 period, respectively. Age-standardized net survival ranged from 13.4% (10.4-17.4) for pancreatic cancer to 94.0% (88.1-100) for thyroid cancer in male patients, and from 11.9% (7.2-19.7) for liver cancer to 95.6% (92.6-98.6-%) for thyroid cancer in female patients. Compared with cases diagnosed in the 1999-2007 period, age-standardized net survival increased in 10 cancer groups, resulting in an overall increase of 5.1 (4.1-6.0) percentage points. The age-standardized net survival in Navarre was 2.7 (1.9-3.4) percentage points higher than that described for Spain for the 2008-2013 period. In Navarre, the survival of cancer patients diagnosed during the 2008-2016 period improved significantly in comparison to the 1999-2007 period. Different factors may explain this improvement, including earlier diagnoses, more effective treatment options, and better healthcare processes. Overall, survival was higher in women than in men. Our results suggest a higher survival rate in Navarre than in Spain.
- Open Access
- 10 June 2023
- Published by Springer Nature in Diabetologia
- Vol. 66 (8) , 1460-1471
Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
Aims/hypothesis: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. Methods: We used the European EPIC-InterAct case–cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). Results: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). Conclusions/interpretation: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes. Graphical
- 10 June 2023
- Published by Springer Nature in Diabetologia
- Vol. 66 (8) , 1460-1471
Open AccessInteraction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study
Aims/hypothesis: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. Methods: We used the European EPIC-InterAct case–cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). Results: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). Conclusions/interpretation: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes. Graphical